
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Impetigo has lots of mimics. Ted Rosen, MD, describes the diagnostic contenders and the treatments that can cure the infection in an era of increasing mupirocin resistance.
Impetigo has lots of mimics. Ted Rosen, MD, describes the diagnostic contenders and the treatments that can cure the infection in an era of increasing mupirocin resistance.
For more webinar videos,






